The Practical Solution PCL (BKK:TPS)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,310	1,205	1,026	1,095	981	650
Market Cap Growth	7.54%	17.43%	-6.29%	11.64%	51.03%	14.85%
Enterprise Value	1,207	1,143	971	1,085	861	542
Last Close Price	3.14	2.73	2.64	2.87	2.51	1.64
PE Ratio	9.33	8.90	8.82	14.45	25.33	12.05
PS Ratio	0.81	0.76	0.76	1.12	1.68	0.88
PB Ratio	1.80	1.70	1.81	2.41	2.41	1.71
P/TBV Ratio	1.84	1.75	1.85	2.43	2.42	1.72
P/FCF Ratio	-	12.86	12.13	-	23.94	45.00
P/OCF Ratio	-	12.29	11.68	-	21.68	17.65
EV/Sales Ratio	0.75	0.72	0.72	1.11	1.47	0.74
EV/EBITDA Ratio	6.64	6.46	6.32	11.13	16.93	7.32
EV/EBIT Ratio	7.24	6.85	6.74	12.36	20.57	8.13
EV/FCF Ratio	17.63	12.19	11.48	-	21.01	37.57
Debt / Equity Ratio	0.08	0.09	0.10	0.23	0.03	0.03
Debt / EBITDA Ratio	0.31	0.35	0.35	1.02	0.22	0.12
Debt / FCF Ratio	0.83	0.68	0.66	-	0.29	0.66
Asset Turnover	1.35	1.35	1.36	1.18	0.84	1.18
Inventory Turnover	10.26	12.47	11.48	7.23	4.61	11.17
Quick Ratio	1.91	1.76	1.47	1.35	1.21	1.83
Current Ratio	2.24	2.16	1.88	1.74	1.82	2.12
Return on Equity (ROE)	20.27%	21.98%	23.58%	17.14%	9.39%	14.19%
Return on Assets (ROA)	8.71%	8.78%	9.06%	6.59%	3.76%	6.69%
Return on Capital (ROIC)	13.96%	14.93%	15.26%	11.23%	6.47%	10.32%
Return on Capital Employed (ROCE)	19.10%	19.20%	20.50%	15.00%	8.20%	14.80%
Earnings Yield	10.75%	11.24%	11.34%	6.92%	3.95%	8.30%
FCF Yield	5.22%	7.78%	8.24%	-14.79%	4.18%	2.22%
Dividend Yield	6.37%	7.32%	6.82%	3.48%	3.19%	2.03%
Payout Ratio	53.20%	55.31%	30.44%	35.45%	28.91%	103.86%
Buyback Yield / Dilution	-10.73%	-7.53%	-9.40%	-7.48%	5.30%	-32.18%
Total Shareholder Return	-4.36%	-0.20%	-2.58%	-3.99%	8.49%	-30.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.